DISCOVERY MEDICINE Key Metrics
Impact Factor
< 5
DISCOVERY MEDICINE Journal Specifications
Indexed in the following public directories
- Web of Science
Overview | |
Publisher | DISCOVERY MEDICINE |
Language | English |
Frequency | Bi-monthly |
General Details | |
Language | English |
Frequency | Bi-monthly |
Publication Start Year | 2001 |
Publisher URL | Visit website |
Website URL | Visit website |
View less
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in DISCOVERY MEDICINE
Gut-Liver Axis: Modulating the Gut Microbiota and Its Metabolic Products as a Potential Therapeutic Strategy for the Treatment of Hepatic Ischemia-Reperfusion Injury.
- 1 Oct 2024
- Discovery medicine
Establishment of a Disease Model Using Patient-Specific Induced Pluripotent Stem Cells-Derived Trabecular Meshwork Cells in a Chinese Primary Open-Angle Glaucoma Mega-Pedigree.
- 1 Oct 2024
- Discovery medicine
Synergistic Inhibition of Colorectal Cancer Cells by Autocrine Motility Factor Peptide and Glycyrrhetinic Acid.
- 1 Oct 2024
- Discovery medicine
Therapeutic Potential of Photobiomodulation in Diabetic Complications.
- 1 Oct 2024
- Discovery medicine
HERV-Derived Syncytin-1 and Syncytin-2 as Sources of Linear and Discontinuous Epitopes in Antiphospholipid Syndrome: A Pivotal Computational Study.
- 1 Oct 2024
- Discovery medicine
Curcumin Alleviates Airway Inflammation in Cough-Variant Asthmatic Rats by Modulating M1/M2 Macrophage Polarization.
- 1 Oct 2024
- Discovery medicine
Gut-Liver Axis: Modulating the Gut Microbiota and Its Metabolic Products as a Potential Therapeutic Strategy for the Treatment of Hepatic Ischemia-Reperfusion Injury.
- 1 Oct 2024
- Discovery medicine
Establishment of a Disease Model Using Patient-Specific Induced Pluripotent Stem Cells-Derived Trabecular Meshwork Cells in a Chinese Primary Open-Angle Glaucoma Mega-Pedigree.
- 1 Oct 2024
- Discovery medicine
Synergistic Inhibition of Colorectal Cancer Cells by Autocrine Motility Factor Peptide and Glycyrrhetinic Acid.
- 1 Oct 2024
- Discovery medicine
Therapeutic Potential of Photobiomodulation in Diabetic Complications.
- 1 Oct 2024
- Discovery medicine
HERV-Derived Syncytin-1 and Syncytin-2 as Sources of Linear and Discontinuous Epitopes in Antiphospholipid Syndrome: A Pivotal Computational Study.
- 1 Oct 2024
- Discovery medicine
Curcumin Alleviates Airway Inflammation in Cough-Variant Asthmatic Rats by Modulating M1/M2 Macrophage Polarization.
- 1 Oct 2024
- Discovery medicine
FAQs on DISCOVERY MEDICINE
How long has DISCOVERY MEDICINE been actively publishing?
DISCOVERY MEDICINE has been in operation since 2001 till date.
What is the publishing frequency of DISCOVERY MEDICINE?
DISCOVERY MEDICINE published with a Bi-monthly frequency.
How many articles did DISCOVERY MEDICINE publish last year?
In 2023, DISCOVERY MEDICINE publsihed 115 articles.
What is the eISSN & pISSN for DISCOVERY MEDICINE?
For DISCOVERY MEDICINE, eISSN is 1944-7930 and pISSN is 1539-6509.
Who is the publisher of DISCOVERY MEDICINE?
DISCOVERY MEDICINE is the publisher of DISCOVERY MEDICINE.